Inventor · disambiguated record
Aparajita Hoskote Chourasia
Also filed as: CHOURASIA APARAJITA HOSKOTE
9 granted patents·12 pending applications·7 citations·filing 2018–2023
79Inventor score
Top patents by PatentIndex Score
21 records- 0189US10513515B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2018·Granted Dec 24, 2019·4 cites·28 claims
- 0286US10905684B2Aminoamide compoundsBIOTHERYX INC·Filed 2019·Granted Feb 2, 2021·2 cites·29 claims
- 0378US10844039B2Substituted isoindolinonesBIOTHERYX INC·Filed 2019·Granted Nov 24, 2020·1 cites·36 claims
- 0467US2022298172A1Protein-targeting compounds and pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 0566US2022153751A1Bifunctional compoundsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 0665US10927104B2Ether compounds and uses thereofBIOTHERYX INC·Filed 2019·Granted Feb 23, 2021·0 cites·26 claims
- 0764US11400084B2Aminoamide compoundsBIOTHERYX INC·Filed 2021·Granted Aug 2, 2022·0 cites·21 claims
- 0864US11352338B2Substituted isoindolinonesBIOTHERYX INC·Filed 2020·Granted Jun 7, 2022·0 cites·22 claims
- 0964US2022088025A1Fused thiophene compoundsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 1064US2024190883A1Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2023·Application pending·0 cites
- 1163US11191769B2Fused thiophene compoundsBIOTHERYX INC·Filed 2019·Granted Dec 7, 2021·0 cites·39 claims
- 1262US11236103B2Bifunctional compoundsBIOTHERYX INC·Filed 2019·Granted Feb 1, 2022·0 cites·33 claims
- 1361US2024174643A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIO THERYX INC·Filed 2023·Application pending·0 cites
- 1459US2024368121A1Estrogen receptor degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1559US2024207268A1Pyrazolylpyrimidines for treating malignant solid tumorBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1656US2024124418A1Pde4 degraders, pharmaceutical compositions, and therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 1756US2024190885A1Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1854US2024197888A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2022·Application pending·0 cites
- 1954US2024025863A1Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2021·Application pending·0 cites
- 2050US2023002371A1Ras protein degraders, pharmaceutical compositions thereof, and their therapeutic applicationsBIOTHERYX INC·Filed 2020·Application pending·0 cites
- 2145US10584133B2Thienopyrimidinone compoundsBIOTHERYX INC·Filed 2019·Granted Mar 10, 2020·0 cites·44 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →